News
A new emergency treatment for allergic reactions will now be available in the UK – in the form of a nasal spray. The first needle-free emergency treatment for anaphylaxis – in the form of a ...
The first needle-free treatment for life-threatening allergic reactions will be made available in the UK as a nasal spray. The medicines regulator has approved the drug EURneffy for emergency use ...
A new emergency treatment for allergic reactions will now be available in the UK – in the form of a nasal spray. The first needle-free emergency treatment for anaphylaxis – in the form of a ...
EURneffy is the trade name for neffy® (epinephrine nasal spray) in the United Kingdom. About neffy® neffy is a nasal spray used for emergency treatment of allergic reactions ...
The first needle-free emergency treatment for anaphylaxis – in the form of a nasal spray – will now be available in the UK. The Medicines and Healthcare products Regulatory Agency (MHRA) has approved ...
EURneffy® (adrenaline nasal spray) Approved in the U.K. as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis) Provided by GlobeNewswire Jul 18, 2025, 6:25:25 AM ...
The MHRA has approved a nasal spray adrenaline formulation that offers the first needle-free alternative for the emergency treatment of anaphylaxis.
Newly approved needle-free adrenaline spray offers longer shelf life, better stability, and easier use, signaling a shift in emergency drug delivery design.
Esketamine monotherapy demonstrated beneficial antidepressant effects at multiple doses for patients with treatment-resistant depression, according to results of a phase 4 randomized trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results